Alicia Serrano
Papers
1
Total Citations
11
H-Index
1
About
Alicia Serrano’s research sits at the critical intersection of molecular diagnostics and infectious disease control, with a focus on improving the accuracy of SARS-CoV-2 detection. Her most cited work, a 2020 study on amplifying the human β-glucuronidase gene, directly addressed a pressing clinical challenge: the high rate of false-negative RT-PCR results in upper respiratory specimens, which can reach 30% in suspected COVID-19 patients. By developing a method to appraise test accuracy, Serrano provided a practical tool to reduce diagnostic uncertainty and improve patient management during the pandemic. This contribution, with 11 citations, underscores her impact on refining gold-standard molecular techniques. Her broader research explores assay optimization and viral detection, aiming to enhance the reliability of public health surveillance. Serrano’s work is notable for its immediate clinical relevance, offering a solution to a problem that affected millions of tests worldwide. For students and researchers, her approach exemplifies how methodical refinement of existing technologies can yield significant real-world benefits, particularly in crisis settings where diagnostic precision is paramount.
Research Focus
Key Achievements
Top Papers
- 1